FDA Drug Application (021654) for LOVAZA by SMITHKLINE BEECHAM

Back to FDA Applications sponsored by SMITHKLINE BEECHAM

Application Number021654
Product Number001
FormCAPSULE;ORAL
Dosage1GM CONTAINS AT LEAST 900MG OF THE ETHYL ESTERS OF OMEGA-3 FATTY ACIDS
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameLOVAZA
Active IngredientOMEGA-3-ACID ETHYL ESTERS

Active IngredientCount
List of drugs with Active Ingredient OMEGA-3-ACID ETHYL ESTERS2


Back to FDA Applications sponsored by SMITHKLINE BEECHAM